Emily Woodworth sold $1000k of BSX
SVP, Global Controller and CAO at BOSTON SCIENTIFIC CORP. 9,887 shares at an average of $101.13, traded Feb 28, 2025, filed Mar 3, 2025.
Score components
- +15RoleOfficer
- +25Trade size$1000k at market
- +20Share of holdings soldSold 86% of holdings
- +15Cluster6 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001225208-25-002655, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 28, 2025 | MOption exercise Common Stock10b5-1 | +7,218 | $42.16 | $304k | 11,519 | Mar 3, 2025 |
| Feb 28, 2025 | SOpen-market sale Common Stock10b5-1 | -9,887 | $101.13 | $1000k | 1,632 | Mar 3, 2025 |
| Mar 1, 2025 | MOption exercise Common Stock10b5-1 | +837 | $0.00 | $0 | 2,469 | Mar 3, 2025 |
| Mar 1, 2025 | FTax withholding Common Stock10b5-1 | -355 | $103.79 | $37k | 2,114 | Mar 3, 2025 |
| Feb 28, 2025 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -7,218 | $0.00 | $0 | 0 | Mar 3, 2025 |
| Mar 1, 2025 | MOption exercise Restricted Stock Unitsderivative10b5-1 | -837 | $0.00 | $0 | 2,514 | Mar 3, 2025 |
Related signals
Other insiders at BOSTON SCIENTIFIC CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 10Weak | BOSTON SCIENTIFIC CORP | Joseph Michael Fitzgerald EVP & Group Pres, Cardiology | $5.3M 50,000 shares | -22% | |
| 40Moderate | BOSTON SCIENTIFIC CORP | Arthur C Butcher EVP& Grp Pres, MedSurg & APAC | $1.8M 17,313 shares | -42% | |
| 25Weak | BOSTON SCIENTIFIC CORP | Joseph Michael Fitzgerald EVP & Group Pres, Cardiology | $5.2M 50,000 shares | -22% | |
| 64Notable | BOSTON SCIENTIFIC CORP | Yoshiaki Fujimori director | $310k 2,901 shares | -58% | |
| 51Moderate | BOSTON SCIENTIFIC CORP | Edward J Ludwig director | $424k 4,000 shares | -18% | |
| 10Weak | BOSTON SCIENTIFIC CORP | Joseph Michael Fitzgerald EVP & Group Pres, Cardiology | $5.3M 50,000 shares | -22% | |
| 25Weak | BOSTON SCIENTIFIC CORP | Joseph Michael Fitzgerald EVP & Group Pres, Cardiology | $5.8M 56,372 shares | -24% | |
| 35Weak | BOSTON SCIENTIFIC CORP | Michael F Mahoney Chairman, President & CEO | $17M 164,443 shares | -10% | |
| 51Moderate | BOSTON SCIENTIFIC CORP | Edward J Ludwig director | $418k 4,000 shares | -15% | |
| 33Weak | BOSTON SCIENTIFIC CORP | Vance R Brown SVP, GC and Corp. Secretary | $514k 4,826 shares | -13% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.